VCCC Centre of Excellence
Client: Honeywell in association with Plenary Health
Value: $20 Million
The Peter MacCallum Centre of Excellence in Cellular Immunotherapy (CoE CIT) project includes the construction of a new purpose built GMP manufacturing facility, to support clinical trial and commercial manufacturing of cell-based therapies for cancer patients both in Australia and the Australasian region. The scope of works centers around the conversion of existing shell space on Level 9 into new clean rooms, with OGTR PC2 certification, fully compliant with PIC/S and with large scale manufacturing capabilities supporting a TGA GMP license for commercial manufacturing of T-Cell products for human therapy. The Level 9 works will also include the construction of new research and administration areas, staff amenities, and plant space. These will occur in parallel with the construction of a new GMP Cryogenics, GMP store and cell logistics on Level 1, supporting the Level 9 facilities.